The Biden Administration on Thursday announced it is setting new policy that will allow it to seize patents for medicines developed with government funding if it believes their prices are too high.

The policy creates a roadmap for the government’s so-called march-in rights, which have never been used before. They would allow the government to grant additional licenses to third parties for products developed using federal funds if the original patent holder does not make them available to the public on reasonable terms.

Under the draft roadmap, seen by Reuters, the government will consider factors including whether only a narrow set of patients can afford the drug, and whether drugmakers are exploiting a health or safety issue by hiking prices.

“We’ll make it clear that when drug companies won’t sell taxpayer funded drugs at reasonable prices, we will be prepared to allow other companies to provide those drugs for less,” White House adviser Lael Brainard said on a press call.

  • @greenskye@lemm.ee
    link
    fedilink
    English
    17 months ago

    Sorry I’m out of touch with this these days, but does the esrb even matter anymore? At least on PC a lot of games aren’t even rated. Or if they are, it’s barely a factor. And lots of kids just play mobile games, which also aren’t rated by the ESRB either.

    • @frezik@midwest.social
      link
      fedilink
      English
      2
      edit-2
      7 months ago

      They’re still a lobbying arm of the industry. They can also slap an AO rating on something and big retailers won’t carry it.

      They also run e3, but that’s pretty much dead now, too.

      Edit: and I realized I should have said “ESA”, not “ESRB”. ESA is the organization, ESRB is the ratings system.